XK
ACOR

Xact Kapitalforvaltning’s Acorda Therapeutics ACOR Stock Holding History

Xact Kapitalforvaltning’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-88
Closed -$30K – 1436
2019
Q3 		$30K Hold
88
– – ﹤0.01% 1429
2019
Q2 		$81K Hold
88
– – ﹤0.01% 1434
2019
Q1 		$140K Hold
88
– – ﹤0.01% 1421
2018
Q4 		$164K Hold
88
– – ﹤0.01% 1458
2018
Q3 		$206K Hold
88
– – ﹤0.01% 1517
2018
Q2 		$301K Buy
88
+15
+21% +$45.9K 0.01% 1352
2018
Q1 		$206K Buy
+73
New +$219K ﹤0.01% 1476

Other funds holding ACOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Xact Kapitalforvaltning's ACOR Position: Q4 2019 in Review

Xact Kapitalforvaltning sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 88 shares — an estimated $30K sold.

Xact Kapitalforvaltning first reported a position in ACOR in Q1 2018 and held it in 7 quarters. The position peaked at $301K in Q2 2018. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Xact Kapitalforvaltning reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Xact Kapitalforvaltning sold 88 Acorda Therapeutics shares in Q4 2019, an estimated $30K.
  • Xact Kapitalforvaltning first reported a position in Acorda Therapeutics in Q1 2018 and held it in 7 quarters.
  • Xact Kapitalforvaltning's Acorda Therapeutics position peaked at $301K in Q2 2018.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2019, filed 14 Feb 2020.